Substituting telehealth services for in-person visits can generate savings of roughly $126 per commercial telehealth visit, according to a new actuarial study from the Alliance for Connected Care.
Substituting telehealth services for in-person visits can generate savings of roughly $126 per commercial telehealth visit, according to a new actuarial study from the Alliance for Connected Care.
The study used data from 5 telehealth companies in the commercial sector: Teladoc, Anthem, American Well, Doctor on Demand, and Optum. According to the Alliance, the study underscores the need for policy reform and highlights the potential savings.
“The findings dispel many of the concerns about adding telehealth services for acute care in Medicare,” author Dale Yamamoto, of Red Quill Consulting, said in a statement. “Reimbursing for telehealth will not increase Medicare expenditures, and it will provide an easy alternative for beneficiaries to get quality healthcare.”
The average estimated cost of a telehealth visit is $40 to $50 per visit, compared with $136 to $176 for the average in-person acute care visit. Using the higher end for both visits, Mr Yamamoto estimated telehealth visits save approximately $126 per visit. In Medicare, replacing acute care services with telehealth visits, which are reimbursed at the same rate, could save Medicare $45 a visit. Furthermore, the study found that 83% of telehealth visits resolved issues during the initial visit.
Krista Drobac, executive director of the Alliance for Connected Care, discussed CMS lifting restrictions on telehealth for the final ACO rule in this month’s American Journal of Accountable Care, a publication of The American Journal of Managed Care.
Some Medicare Advantage plans have start offering telehealth, but most seniors in fee-for-service Medicare lack access to these services because of restrictions in the statute, according to the Alliance.
The study also dispels concerns that the convenience of telemedicine will cause overutilization. Mr Yamamoto found that the average number of telehealth visits across vendors was just 1.3 visits per patient per year. Since telehealth visits are used to treat fairly routine, non-emergent conditions, such as sinusitis, colds, and urinary tract infections, telehealth can replace unnecessary in-person visits to the emergency department or urgent care centers.
“This study is another step toward demonstrating the value proposition of telehealth in Medicare, and dispelling the myth that telehealth will increase costs to Medicare,” Ms Drobac said. “It’s time to change the statute and give seniors access to telehealth services.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More